These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 26975700)

  • 21. Stereotactic ablative body radiotherapy (SABR): an alternative to surgery in stage I-II non-small-cell cancer of the lung?
    Mirimanoff RO
    Chin Clin Oncol; 2015 Dec; 4(4):42. PubMed ID: 26730754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiographic changes after lung stereotactic ablative radiotherapy (SABR)--can we distinguish recurrence from fibrosis? A systematic review of the literature.
    Huang K; Dahele M; Senan S; Guckenberger M; Rodrigues GB; Ward A; Boldt RG; Palma DA
    Radiother Oncol; 2012 Mar; 102(3):335-42. PubMed ID: 22305958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors.
    Binkley MS; Shrager JB; Chaudhuri A; Popat R; Maxim PG; Shultz DB; Diehn M; Loo BW
    Radiat Oncol; 2016 Mar; 11():40. PubMed ID: 26975700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung.
    Binkley MS; King MT; Shrager JB; Bush K; Chaudhuri AA; Popat R; Gensheimer MF; Maxim PG; Henry Guo H; Diehn M; Nair VS; Loo BW
    Radiother Oncol; 2017 May; 123(2):270-275. PubMed ID: 28460826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings.
    Nakajima N; Sugawara Y; Kataoka M; Hamamoto Y; Ochi T; Sakai S; Takahashi T; Kajihara M; Teramoto N; Yamashita M; Mochizuki T
    Ann Nucl Med; 2013 Apr; 27(3):261-70. PubMed ID: 23299492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.
    Siva S; Kirby K; Caine H; Pham D; Kron T; Te Marvelde L; Whalley D; Stevens MJ; Foroudi F; MacManus M; Ball D; Eade T
    Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):353-61. PubMed ID: 25698068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR).
    Chaudhuri AA; Binkley MS; Rigdon J; Carter JN; Aggarwal S; Dudley SA; Qian Y; Kumar KA; Hara WY; Gensheimer M; Nair VS; Maxim PG; Shultz DB; Bush K; Trakul N; Le QT; Diehn M; Loo BW; Guo HH
    Radiother Oncol; 2016 Jun; 119(3):454-60. PubMed ID: 27267049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with severe emphysema have a low risk of radiation pneumonitis following stereotactic body radiotherapy.
    Ishijima M; Nakayama H; Itonaga T; Tajima Y; Shiraishi S; Okubo M; Mikami R; Tokuuye K
    Br J Radiol; 2015 Feb; 88(1046):20140596. PubMed ID: 25490255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up of high-risk patients in the National Emphysema Treatment Trial.
    Kaplan RM; Sun Q; Naunheim KS; Ries AL
    Ann Thorac Surg; 2014 Nov; 98(5):1782-9. PubMed ID: 25201722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis.
    Zheng X; Schipper M; Kidwell K; Lin J; Reddy R; Ren Y; Chang A; Lv F; Orringer M; Spring Kong FM
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):603-11. PubMed ID: 25052562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema.
    Binkley MS; Shrager JB; Leung AN; Popat R; Trakul N; Atwood TF; Chaudhuri A; Maxim PG; Diehn M; Loo BW
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):216-23. PubMed ID: 25015205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236.
    Stanic S; Paulus R; Timmerman RD; Michalski JM; Barriger RB; Bezjak A; Videtic GM; Bradley J
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1092-9. PubMed ID: 24661663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spatial and dose-response analysis of fibrotic lung changes after stereotactic body radiation therapy.
    Vinogradskiy Y; Diot Q; Kavanagh B; Schefter T; Gaspar L; Miften M
    Med Phys; 2013 Aug; 40(8):081712. PubMed ID: 23927309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative lung volume change depending on the resected lobe.
    Sengul AT; Sahin B; Celenk C; Basoglu A
    Thorac Cardiovasc Surg; 2013 Mar; 61(2):131-7. PubMed ID: 23475808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors.
    Diot Q; Kavanagh B; Schefter T; Gaspar L; Stuhr K; Miften M
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):1024-30. PubMed ID: 22583607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evidence-based estimate on the size of the potential patient pool for lung volume reduction surgery.
    Akuthota P; Litmanovich D; Zutler M; Boiselle PM; Bankier AA; Roberts DH; Celli BR; DeCamp MM; Berger RL
    Ann Thorac Surg; 2012 Jul; 94(1):205-11. PubMed ID: 22571881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors.
    Trakul N; Chang CN; Harris J; Chapman C; Rao A; Shen J; Quinlan-Davidson S; Filion EJ; Wakelee HA; Colevas AD; Whyte RI; Dieterich S; Maxim PG; Hristov D; Tran P; Le QT; Loo BW; Diehn M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):231-7. PubMed ID: 22381907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiological changes after stereotactic radiotherapy for stage I lung cancer.
    Dahele M; Palma D; Lagerwaard F; Slotman B; Senan S
    J Thorac Oncol; 2011 Jul; 6(7):1221-8. PubMed ID: 21623237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung volume reduction surgery using the NETT selection criteria.
    Ginsburg ME; Thomashow BM; Yip CK; DiMango AM; Maxfield RA; Bartels MN; Jellen P; Bulman WA; Lederer D; Brogan FL; Gorenstein LA; Sonett JR
    Ann Thorac Surg; 2011 May; 91(5):1556-60; discussion 1561. PubMed ID: 21459360
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.